| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |